Keynotes

1ST GENERAL SESSION KEYNOTE SPEAKER SUNDAY OCT. 27

Rolf Benirschke

Rolf’s third season as a placekicker in the NFL was cut short when he collapsed on a cross-country team flight while battling ulcerative colitis. He would need two emergency surgeries within six days as his life hung in the balance for six weeks in the intensive care unit. After a miraculous comeback, he returned to play seven more seasons with the San Diego Chargers. Following his NFL career, Rolf dedicated his life to patient advocacy. He founded Legacy Health Strategies, a patient engagement company and The Grateful Patient Project.

 

Using his warm and engaging style, Rolf shares his inspirational story of loss, perseverance and hope for one reason—to encourage others.

 

Rolf has authored three books, including his autobiography, Alive & Kicking. He also currently works with UCSD Health helping to transform their culture and patient experience. He speaks to audiences around the country on the importance of the indomitable spirit, culture, connection and the patient experience. He also serves as a patient advocate for state/national legislation and is a champion for ongoing research and innovation.

2ND GENERAL SESSION SPEAKER MONDAY OCT. 28

Scott Gottlieb, MD

Scott Gottlieb, MD is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration.  His work focuses on advancing public health through the development and implementation of innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety.

 

Dr. Gottlieb advocates for advancing the health of patients, promoting healthcare access, and driving innovation.  The agency’s historic and prolific advances in new policy distinguished his tenure as the FDA’s commissioner, in addition to a record-setting number of approvals of novel drugs, medical devices, and generic medicines.

 

Under his leadership, the FDA implemented new reforms to standardize drug reviews and make improvements of post market data collection and the use of real world evidence.

 

A healthcare futurist, he has worked as a venture capitalist and founder and board member to companies that have developed new medicines and advance the delivery of healthcare.

 

He is widely published in medical journals and periodicals and has  appeared as a guest commentator on CNBC.  Fortune magazine recognized him as one of the “World’s 50 Greatest Leaders” in 2018 and again in 2019.  He was also named one of the most influential physician executive and leaders by “Modern Healthcare”, Time magazine also named him one of its “50 People Transforming Healthcare in 2018”.